Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

FOXM1 contributes to treatment failure in acute myeloid leukemia.

Khan I, Halasi M, Patel A, Schultz R, Kalakota N, Chen YH, Aardsma N, Liu L, Crispino JD, Mahmud N, Frankfurt O, Gartel AL.

JCI Insight. 2018 Aug 9;3(15). pii: 121583. doi: 10.1172/jci.insight.121583. eCollection 2018 Aug 9.

2.

Honokiol is a FOXM1 antagonist.

Halasi M, Hitchinson B, Shah BN, Váraljai R, Khan I, Benevolenskaya EV, Gaponenko V, Arbiser JL, Gartel AL.

Cell Death Dis. 2018 Jan 24;9(2):84. doi: 10.1038/s41419-017-0156-7.

3.

FOXM1 in Cancer: Interactions and Vulnerabilities.

Gartel AL.

Cancer Res. 2017 Jun 15;77(12):3135-3139. doi: 10.1158/0008-5472.CAN-16-3566. Epub 2017 Jun 5. Review.

4.

Nuclear FOXM1 drives chemoresistance in AML.

Khan I, Halasi M, Zia MF, Gann P, Gaitonde S, Mahmud N, Gartel AL.

Leukemia. 2017 Jan;31(1):251-255. doi: 10.1038/leu.2016.270. Epub 2016 Oct 3. No abstract available.

PMID:
27694928
5.

A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS.

Halasi M, Váraljai R, Benevolenskaya E, Gartel AL.

J Biol Chem. 2016 Jan 1;291(1):142-8. doi: 10.1074/jbc.M115.678227. Epub 2015 Nov 11.

6.

Mutual Regulation of FOXM1, NPM and ARF Proteins.

Pandit B, Gartel AL.

J Cancer. 2015 Apr 28;6(6):538-41. doi: 10.7150/jca.11766. eCollection 2015.

7.

Targeting FOXM1 auto-regulation in cancer.

Gartel AL.

Cancer Biol Ther. 2015;16(2):185-6. doi: 10.4161/15384047.2014.987566. No abstract available.

8.

Proteasome inhibitors suppress the protein expression of mutant p53.

Halasi M, Pandit B, Gartel AL.

Cell Cycle. 2014;13(20):3202-6. doi: 10.4161/15384101.2014.950132.

9.

Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors.

Gartel AL.

Scientifica (Cairo). 2014;2014:596528. doi: 10.1155/2014/596528. Epub 2014 Jun 24. Review.

10.

Found in transcription: FOXO1 upregulates miRNAs on chromosome X.

Gartel AL.

Cell Cycle. 2013 Aug 15;12(16):2523. doi: 10.4161/cc.25829. Epub 2013 Jul 29. No abstract available.

11.

ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors.

Halasi M, Wang M, Chavan TS, Gaponenko V, Hay N, Gartel AL.

Biochem J. 2013 Sep 1;454(2):201-8. doi: 10.1042/BJ20130282.

12.

Thiazole Antibiotics Siomycin a and Thiostrepton Inhibit the Transcriptional Activity of FOXM1.

Gartel AL.

Front Oncol. 2013 Jun 6;3:150. doi: 10.3389/fonc.2013.00150. eCollection 2013. No abstract available.

13.

Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth.

Halasi M, Pandit B, Wang M, Nogueira V, Hay N, Gartel AL.

Am J Pathol. 2013 Jul;183(1):257-65. doi: 10.1016/j.ajpath.2013.03.012. Epub 2013 May 10.

14.

FOX(M1) news--it is cancer.

Halasi M, Gartel AL.

Mol Cancer Ther. 2013 Mar;12(3):245-54. doi: 10.1158/1535-7163.MCT-12-0712. Epub 2013 Feb 26. Review.

15.

Paradoxical inhibition of cellular protein expression by proteasome inhibitors.

Gartel AL.

Biomol Concepts. 2012 Dec;3(6):593-5. doi: 10.1515/bmc-2012-0029.

PMID:
25436560
16.

Targeting FOXM1 in cancer.

Halasi M, Gartel AL.

Biochem Pharmacol. 2013 Mar 1;85(5):644-652. doi: 10.1016/j.bcp.2012.10.013. Epub 2012 Oct 24. Review.

PMID:
23103567
17.

Guidelines for the use and interpretation of assays for monitoring autophagy.

Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, Al-Younes HM, Al-Zeer MA, Albert ML, Albin RL, Alegre-Abarrategui J, Aleo MF, Alirezaei M, Almasan A, Almonte-Becerril M, Amano A, Amaravadi R, Amarnath S, Amer AO, Andrieu-Abadie N, Anantharam V, Ann DK, Anoopkumar-Dukie S, Aoki H, Apostolova N, Arancia G, Aris JP, Asanuma K, Asare NY, Ashida H, Askanas V, Askew DS, Auberger P, Baba M, Backues SK, Baehrecke EH, Bahr BA, Bai XY, Bailly Y, Baiocchi R, Baldini G, Balduini W, Ballabio A, Bamber BA, Bampton ET, Bánhegyi G, Bartholomew CR, Bassham DC, Bast RC Jr, Batoko H, Bay BH, Beau I, Béchet DM, Begley TJ, Behl C, Behrends C, Bekri S, Bellaire B, Bendall LJ, Benetti L, Berliocchi L, Bernardi H, Bernassola F, Besteiro S, Bhatia-Kissova I, Bi X, Biard-Piechaczyk M, Blum JS, Boise LH, Bonaldo P, Boone DL, Bornhauser BC, Bortoluci KR, Bossis I, Bost F, Bourquin JP, Boya P, Boyer-Guittaut M, Bozhkov PV, Brady NR, Brancolini C, Brech A, Brenman JE, Brennand A, Bresnick EH, Brest P, Bridges D, Bristol ML, Brookes PS, Brown EJ, Brumell JH, Brunetti-Pierri N, Brunk UT, Bulman DE, Bultman SJ, Bultynck G, Burbulla LF, Bursch W, Butchar JP, Buzgariu W, Bydlowski SP, Cadwell K, Cahová M, Cai D, Cai J, Cai Q, Calabretta B, Calvo-Garrido J, Camougrand N, Campanella M, Campos-Salinas J, Candi E, Cao L, Caplan AB, Carding SR, Cardoso SM, Carew JS, Carlin CR, Carmignac V, Carneiro LA, Carra S, Caruso RA, Casari G, Casas C, Castino R, Cebollero E, Cecconi F, Celli J, Chaachouay H, Chae HJ, Chai CY, Chan DC, Chan EY, Chang RC, Che CM, Chen CC, Chen GC, Chen GQ, Chen M, Chen Q, Chen SS, Chen W, Chen X, Chen X, Chen X, Chen YG, Chen Y, Chen Y, Chen YJ, Chen Z, Cheng A, Cheng CH, Cheng Y, Cheong H, Cheong JH, Cherry S, Chess-Williams R, Cheung ZH, Chevet E, Chiang HL, Chiarelli R, Chiba T, Chin LS, Chiou SH, Chisari FV, Cho CH, Cho DH, Choi AM, Choi D, Choi KS, Choi ME, Chouaib S, Choubey D, Choubey V, Chu CT, Chuang TH, Chueh SH, Chun T, Chwae YJ, Chye ML, Ciarcia R, Ciriolo MR, Clague MJ, Clark RS, Clarke PG, Clarke R, Codogno P, Coller HA, Colombo MI, Comincini S, Condello M, Condorelli F, Cookson MR, Coombs GH, Coppens I, Corbalan R, Cossart P, Costelli P, Costes S, Coto-Montes A, Couve E, Coxon FP, Cregg JM, Crespo JL, Cronjé MJ, Cuervo AM, Cullen JJ, Czaja MJ, D'Amelio M, Darfeuille-Michaud A, Davids LM, Davies FE, De Felici M, de Groot JF, de Haan CA, De Martino L, De Milito A, De Tata V, Debnath J, Degterev A, Dehay B, Delbridge LM, Demarchi F, Deng YZ, Dengjel J, Dent P, Denton D, Deretic V, Desai SD, Devenish RJ, Di Gioacchino M, Di Paolo G, Di Pietro C, Díaz-Araya G, Díaz-Laviada I, Diaz-Meco MT, Diaz-Nido J, Dikic I, Dinesh-Kumar SP, Ding WX, Distelhorst CW, Diwan A, Djavaheri-Mergny M, Dokudovskaya S, Dong Z, Dorsey FC, Dosenko V, Dowling JJ, Doxsey S, Dreux M, Drew ME, Duan Q, Duchosal MA, Duff K, Dugail I, Durbeej M, Duszenko M, Edelstein CL, Edinger AL, Egea G, Eichinger L, Eissa NT, Ekmekcioglu S, El-Deiry WS, Elazar Z, Elgendy M, Ellerby LM, Eng KE, Engelbrecht AM, Engelender S, Erenpreisa J, Escalante R, Esclatine A, Eskelinen EL, Espert L, Espina V, Fan H, Fan J, Fan QW, Fan Z, Fang S, Fang Y, Fanto M, Fanzani A, Farkas T, Farré JC, Faure M, Fechheimer M, Feng CG, Feng J, Feng Q, Feng Y, Fésüs L, Feuer R, Figueiredo-Pereira ME, Fimia GM, Fingar DC, Finkbeiner S, Finkel T, Finley KD, Fiorito F, Fisher EA, Fisher PB, Flajolet M, Florez-McClure ML, Florio S, Fon EA, Fornai F, Fortunato F, Fotedar R, Fowler DH, Fox HS, Franco R, Frankel LB, Fransen M, Fuentes JM, Fueyo J, Fujii J, Fujisaki K, Fujita E, Fukuda M, Furukawa RH, Gaestel M, Gailly P, Gajewska M, Galliot B, Galy V, Ganesh S, Ganetzky B, Ganley IG, Gao FB, Gao GF, Gao J, Garcia L, Garcia-Manero G, Garcia-Marcos M, Garmyn M, Gartel AL, Gatti E, Gautel M, Gawriluk TR, Gegg ME, Geng J, Germain M, Gestwicki JE, Gewirtz DA, Ghavami S, Ghosh P, Giammarioli AM, Giatromanolaki AN, Gibson SB, Gilkerson RW, Ginger ML, Ginsberg HN, Golab J, Goligorsky MS, Golstein P, Gomez-Manzano C, Goncu E, Gongora C, Gonzalez CD, Gonzalez R, González-Estévez C, González-Polo RA, Gonzalez-Rey E, Gorbunov NV, Gorski S, Goruppi S, Gottlieb RA, Gozuacik D, Granato GE, Grant GD, Green KN, Gregorc A, Gros F, Grose C, Grunt TW, Gual P, Guan JL, Guan KL, Guichard SM, Gukovskaya AS, Gukovsky I, Gunst J, Gustafsson AB, Halayko AJ, Hale AN, Halonen SK, Hamasaki M, Han F, Han T, Hancock MK, Hansen M, Harada H, Harada M, Hardt SE, Harper JW, Harris AL, Harris J, Harris SD, Hashimoto M, Haspel JA, Hayashi S, Hazelhurst LA, He C, He YW, Hébert MJ, Heidenreich KA, Helfrich MH, Helgason GV, Henske EP, Herman B, Herman PK, Hetz C, Hilfiker S, Hill JA, Hocking LJ, Hofman P, Hofmann TG, Höhfeld J, Holyoake TL, Hong MH, Hood DA, Hotamisligil GS, Houwerzijl EJ, Høyer-Hansen M, Hu B, Hu CA, Hu HM, Hua Y, Huang C, Huang J, Huang S, Huang WP, Huber TB, Huh WK, Hung TH, Hupp TR, Hur GM, Hurley JB, Hussain SN, Hussey PJ, Hwang JJ, Hwang S, Ichihara A, Ilkhanizadeh S, Inoki K, Into T, Iovane V, Iovanna JL, Ip NY, Isaka Y, Ishida H, Isidoro C, Isobe K, Iwasaki A, Izquierdo M, Izumi Y, Jaakkola PM, Jäättelä M, Jackson GR, Jackson WT, Janji B, Jendrach M, Jeon JH, Jeung EB, Jiang H, Jiang H, Jiang JX, Jiang M, Jiang Q, Jiang X, Jiang X, Jiménez A, Jin M, Jin S, Joe CO, Johansen T, Johnson DE, Johnson GV, Jones NL, Joseph B, Joseph SK, Joubert AM, Juhász G, Juillerat-Jeanneret L, Jung CH, Jung YK, Kaarniranta K, Kaasik A, Kabuta T, Kadowaki M, Kagedal K, Kamada Y, Kaminskyy VO, Kampinga HH, Kanamori H, Kang C, Kang KB, Kang KI, Kang R, Kang YA, Kanki T, Kanneganti TD, Kanno H, Kanthasamy AG, Kanthasamy A, Karantza V, Kaushal GP, Kaushik S, Kawazoe Y, Ke PY, Kehrl JH, Kelekar A, Kerkhoff C, Kessel DH, Khalil H, Kiel JA, Kiger AA, Kihara A, Kim DR, Kim DH, Kim DH, Kim EK, Kim HR, Kim JS, Kim JH, Kim JC, Kim JK, Kim PK, Kim SW, Kim YS, Kim Y, Kimchi A, Kimmelman AC, King JS, Kinsella TJ, Kirkin V, Kirshenbaum LA, Kitamoto K, Kitazato K, Klein L, Klimecki WT, Klucken J, Knecht E, Ko BC, Koch JC, Koga H, Koh JY, Koh YH, Koike M, Komatsu M, Kominami E, Kong HJ, Kong WJ, Korolchuk VI, Kotake Y, Koukourakis MI, Kouri Flores JB, Kovács AL, Kraft C, Krainc D, Krämer H, Kretz-Remy C, Krichevsky AM, Kroemer G, Krüger R, Krut O, Ktistakis NT, Kuan CY, Kucharczyk R, Kumar A, Kumar R, Kumar S, Kundu M, Kung HJ, Kurz T, Kwon HJ, La Spada AR, Lafont F, Lamark T, Landry J, Lane JD, Lapaquette P, Laporte JF, László L, Lavandero S, Lavoie JN, Layfield R, Lazo PA, Le W, Le Cam L, Ledbetter DJ, Lee AJ, Lee BW, Lee GM, Lee J, Lee JH, Lee M, Lee MS, Lee SH, Leeuwenburgh C, Legembre P, Legouis R, Lehmann M, Lei HY, Lei QY, Leib DA, Leiro J, Lemasters JJ, Lemoine A, Lesniak MS, Lev D, Levenson VV, Levine B, Levy E, Li F, Li JL, Li L, Li S, Li W, Li XJ, Li YB, Li YP, Liang C, Liang Q, Liao YF, Liberski PP, Lieberman A, Lim HJ, Lim KL, Lim K, Lin CF, Lin FC, Lin J, Lin JD, Lin K, Lin WW, Lin WC, Lin YL, Linden R, Lingor P, Lippincott-Schwartz J, Lisanti MP, Liton PB, Liu B, Liu CF, Liu K, Liu L, Liu QA, Liu W, Liu YC, Liu Y, Lockshin RA, Lok CN, Lonial S, Loos B, Lopez-Berestein G, López-Otín C, Lossi L, Lotze MT, Lőw P, Lu B, Lu B, Lu B, Lu Z, Luciano F, Lukacs NW, Lund AH, Lynch-Day MA, Ma Y, Macian F, MacKeigan JP, Macleod KF, Madeo F, Maiuri L, Maiuri MC, Malagoli D, Malicdan MC, Malorni W, Man N, Mandelkow EM, Manon S, Manov I, Mao K, Mao X, Mao Z, Marambaud P, Marazziti D, Marcel YL, Marchbank K, Marchetti P, Marciniak SJ, Marcondes M, Mardi M, Marfe G, Mariño G, Markaki M, Marten MR, Martin SJ, Martinand-Mari C, Martinet W, Martinez-Vicente M, Masini M, Matarrese P, Matsuo S, Matteoni R, Mayer A, Mazure NM, McConkey DJ, McConnell MJ, McDermott C, McDonald C, McInerney GM, McKenna SL, McLaughlin B, McLean PJ, McMaster CR, McQuibban GA, Meijer AJ, Meisler MH, Meléndez A, Melia TJ, Melino G, Mena MA, Menendez JA, Menna-Barreto RF, Menon MB, Menzies FM, Mercer CA, Merighi A, Merry DE, Meschini S, Meyer CG, Meyer TF, Miao CY, Miao JY, Michels PA, Michiels C, Mijaljica D, Milojkovic A, Minucci S, Miracco C, Miranti CK, Mitroulis I, Miyazawa K, Mizushima N, Mograbi B, Mohseni S, Molero X, Mollereau B, Mollinedo F, Momoi T, Monastyrska I, Monick MM, Monteiro MJ, Moore MN, Mora R, Moreau K, Moreira PI, Moriyasu Y, Moscat J, Mostowy S, Mottram JC, Motyl T, Moussa CE, Müller S, Muller S, Münger K, Münz C, Murphy LO, Murphy ME, Musarò A, Mysorekar I, Nagata E, Nagata K, Nahimana A, Nair U, Nakagawa T, Nakahira K, Nakano H, Nakatogawa H, Nanjundan M, Naqvi NI, Narendra DP, Narita M, Navarro M, Nawrocki ST, Nazarko TY, Nemchenko A, Netea MG, Neufeld TP, Ney PA, Nezis IP, Nguyen HP, Nie D, Nishino I, Nislow C, Nixon RA, Noda T, Noegel AA, Nogalska A, Noguchi S, Notterpek L, Novak I, Nozaki T, Nukina N, Nürnberger T, Nyfeler B, Obara K, Oberley TD, Oddo S, Ogawa M, Ohashi T, Okamoto K, Oleinick NL, Oliver FJ, Olsen LJ, Olsson S, Opota O, Osborne TF, Ostrander GK, Otsu K, Ou JH, Ouimet M, Overholtzer M, Ozpolat B, Paganetti P, Pagnini U, Pallet N, Palmer GE, Palumbo C, Pan T, Panaretakis T, Pandey UB, Papackova Z, Papassideri I, Paris I, Park J, Park OK, Parys JB, Parzych KR, Patschan S, Patterson C, Pattingre S, Pawelek JM, Peng J, Perlmutter DH, Perrotta I, Perry G, Pervaiz S, Peter M, Peters GJ, Petersen M, Petrovski G, Phang JM, Piacentini M, Pierre P, Pierrefite-Carle V, Pierron G, Pinkas-Kramarski R, Piras A, Piri N, Platanias LC, Pöggeler S, Poirot M, Poletti A, Poüs C, Pozuelo-Rubio M, Prætorius-Ibba M, Prasad A, Prescott M, Priault M, Produit-Zengaffinen N, Progulske-Fox A, Proikas-Cezanne T, Przedborski S, Przyklenk K, Puertollano R, Puyal J, Qian SB, Qin L, Qin ZH, Quaggin SE, Raben N, Rabinowich H, Rabkin SW, Rahman I, Rami A, Ramm G, Randall G, Randow F, Rao VA, Rathmell JC, Ravikumar B, Ray SK, Reed BH, Reed JC, Reggiori F, Régnier-Vigouroux A, Reichert AS, Reiners JJ Jr, Reiter RJ, Ren J, Revuelta JL, Rhodes CJ, Ritis K, Rizzo E, Robbins J, Roberge M, Roca H, Roccheri MC, Rocchi S, Rodemann HP, Rodríguez de Córdoba S, Rohrer B, Roninson IB, Rosen K, Rost-Roszkowska MM, Rouis M, Rouschop KM, Rovetta F, Rubin BP, Rubinsztein DC, Ruckdeschel K, Rucker EB 3rd, Rudich A, Rudolf E, Ruiz-Opazo N, Russo R, Rusten TE, Ryan KM, Ryter SW, Sabatini DM, Sadoshima J, Saha T, Saitoh T, Sakagami H, Sakai Y, Salekdeh GH, Salomoni P, Salvaterra PM, Salvesen G, Salvioli R, Sanchez AM, Sánchez-Alcázar JA, Sánchez-Prieto R, Sandri M, Sankar U, Sansanwal P, Santambrogio L, Saran S, Sarkar S, Sarwal M, Sasakawa C, Sasnauskiene A, Sass M, Sato K, Sato M, Schapira AH, Scharl M, Schätzl HM, Scheper W, Schiaffino S, Schneider C, Schneider ME, Schneider-Stock R, Schoenlein PV, Schorderet DF, Schüller C, Schwartz GK, Scorrano L, Sealy L, Seglen PO, Segura-Aguilar J, Seiliez I, Seleverstov O, Sell C, Seo JB, Separovic D, Setaluri V, Setoguchi T, Settembre C, Shacka JJ, Shanmugam M, Shapiro IM, Shaulian E, Shaw RJ, Shelhamer JH, Shen HM, Shen WC, Sheng ZH, Shi Y, Shibuya K, Shidoji Y, Shieh JJ, Shih CM, Shimada Y, Shimizu S, Shintani T, Shirihai OS, Shore GC, Sibirny AA, Sidhu SB, Sikorska B, Silva-Zacarin EC, Simmons A, Simon AK, Simon HU, Simone C, Simonsen A, Sinclair DA, Singh R, Sinha D, Sinicrope FA, Sirko A, Siu PM, Sivridis E, Skop V, Skulachev VP, Slack RS, Smaili SS, Smith DR, Soengas MS, Soldati T, Song X, Sood AK, Soong TW, Sotgia F, Spector SA, Spies CD, Springer W, Srinivasula SM, Stefanis L, Steffan JS, Stendel R, Stenmark H, Stephanou A, Stern ST, Sternberg C, Stork B, Strålfors P, Subauste CS, Sui X, Sulzer D, Sun J, Sun SY, Sun ZJ, Sung JJ, Suzuki K, Suzuki T, Swanson MS, Swanton C, Sweeney ST, Sy LK, Szabadkai G, Tabas I, Taegtmeyer H, Tafani M, Takács-Vellai K, Takano Y, Takegawa K, Takemura G, Takeshita F, Talbot NJ, Tan KS, Tanaka K, Tanaka K, Tang D, Tang D, Tanida I, Tannous BA, Tavernarakis N, Taylor GS, Taylor GA, Taylor JP, Terada LS, Terman A, Tettamanti G, Thevissen K, Thompson CB, Thorburn A, Thumm M, Tian F, Tian Y, Tocchini-Valentini G, Tolkovsky AM, Tomino Y, Tönges L, Tooze SA, Tournier C, Tower J, Towns R, Trajkovic V, Travassos LH, Tsai TF, Tschan MP, Tsubata T, Tsung A, Turk B, Turner LS, Tyagi SC, Uchiyama Y, Ueno T, Umekawa M, Umemiya-Shirafuji R, Unni VK, Vaccaro MI, Valente EM, Van den Berghe G, van der Klei IJ, van Doorn W, van Dyk LF, van Egmond M, van Grunsven LA, Vandenabeele P, Vandenberghe WP, Vanhorebeek I, Vaquero EC, Velasco G, Vellai T, Vicencio JM, Vierstra RD, Vila M, Vindis C, Viola G, Viscomi MT, Voitsekhovskaja OV, von Haefen C, Votruba M, Wada K, Wade-Martins R, Walker CL, Walsh CM, Walter J, Wan XB, Wang A, Wang C, Wang D, Wang F, Wang F, Wang G, Wang H, Wang HG, Wang HD, Wang J, Wang K, Wang M, Wang RC, Wang X, Wang X, Wang YJ, Wang Y, Wang Z, Wang ZC, Wang Z, Wansink DG, Ward DM, Watada H, Waters SL, Webster P, Wei L, Weihl CC, Weiss WA, Welford SM, Wen LP, Whitehouse CA, Whitton JL, Whitworth AJ, Wileman T, Wiley JW, Wilkinson S, Willbold D, Williams RL, Williamson PR, Wouters BG, Wu C, Wu DC, Wu WK, Wyttenbach A, Xavier RJ, Xi Z, Xia P, Xiao G, Xie Z, Xie Z, Xu DZ, Xu J, Xu L, Xu X, Yamamoto A, Yamamoto A, Yamashina S, Yamashita M, Yan X, Yanagida M, Yang DS, Yang E, Yang JM, Yang SY, Yang W, Yang WY, Yang Z, Yao MC, Yao TP, Yeganeh B, Yen WL, Yin JJ, Yin XM, Yoo OJ, Yoon G, Yoon SY, Yorimitsu T, Yoshikawa Y, Yoshimori T, Yoshimoto K, You HJ, Youle RJ, Younes A, Yu L, Yu L, Yu SW, Yu WH, Yuan ZM, Yue Z, Yun CH, Yuzaki M, Zabirnyk O, Silva-Zacarin E, Zacks D, Zacksenhaus E, Zaffaroni N, Zakeri Z, Zeh HJ 3rd, Zeitlin SO, Zhang H, Zhang HL, Zhang J, Zhang JP, Zhang L, Zhang L, Zhang MY, Zhang XD, Zhao M, Zhao YF, Zhao Y, Zhao ZJ, Zheng X, Zhivotovsky B, Zhong Q, Zhou CZ, Zhu C, Zhu WG, Zhu XF, Zhu X, Zhu Y, Zoladek T, Zong WX, Zorzano A, Zschocke J, Zuckerbraun B.

Autophagy. 2012 Apr;8(4):445-544.

18.

The oncogenic transcription factor FOXM1 and anticancer therapy.

Gartel AL.

Cell Cycle. 2012 Sep 15;11(18):3341-2. doi: 10.4161/cc.21841. Epub 2012 Aug 23.

19.

Combination treatment with bortezomib and thiostrepton is effective against tumor formation in mouse models of DEN/PB-induced liver carcinogenesis.

Wang M, Halasi M, Kabirov K, Banerjee A, Landolfi J, Lyubimov AV, Gartel AL.

Cell Cycle. 2012 Sep 15;11(18):3370-2. doi: 10.4161/cc.21290. Epub 2012 Aug 16.

20.

Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage.

Halasi M, Gartel AL.

PLoS One. 2012;7(2):e31761. doi: 10.1371/journal.pone.0031761. Epub 2012 Feb 29.

21.

Combination with bortezomib enhances the antitumor effects of nanoparticle-encapsulated thiostrepton.

Wang M, Gartel AL.

Cancer Biol Ther. 2012 Feb 1;13(3):184-9. doi: 10.4161/cbt.13.3.18875.

22.

Mechanisms of apoptosis induced by anticancer compounds in melanoma cells.

Gartel AL.

Curr Top Med Chem. 2012;12(1):50-2. Review.

PMID:
22280162
23.
24.

Thiostrepton, proteasome inhibitors and FOXM1.

Gartel AL.

Cell Cycle. 2011 Dec 15;10(24):4341-2. doi: 10.4161/cc.10.24.18544. Epub 2011 Dec 15. No abstract available.

25.

Proteasome inhibitors suppress expression of NPM and ARF proteins.

Pandit B, Gartel AL.

Cell Cycle. 2011 Nov 15;10(22):3827-9. doi: 10.4161/cc.10.22.18211. Epub 2011 Nov 15.

26.

Nucleophosmin interacts with FOXM1 and modulates the level and localization of FOXM1 in human cancer cells.

Bhat UG, Jagadeeswaran R, Halasi M, Gartel AL.

J Biol Chem. 2011 Dec 2;286(48):41425-33. doi: 10.1074/jbc.M111.270843. Epub 2011 Oct 6.

27.

FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy.

Pandit B, Gartel AL.

Cell Cycle. 2011 Oct 1;10(19):3269-73. doi: 10.4161/cc.10.19.17735. Epub 2011 Oct 1.

28.

Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts.

Wang M, Gartel AL.

Mol Cancer Ther. 2011 Dec;10(12):2287-97. doi: 10.1158/1535-7163.MCT-11-0536. Epub 2011 Sep 8.

29.

Thiazole antibiotic thiostrepton synergize with bortezomib to induce apoptosis in cancer cells.

Pandit B, Gartel AL.

PLoS One. 2011 Feb 18;6(2):e17110. doi: 10.1371/journal.pone.0017110.

30.

Proteasome inhibitors induce p53-independent apoptosis in human cancer cells.

Pandit B, Gartel AL.

Am J Pathol. 2011 Jan;178(1):355-60. doi: 10.1016/j.ajpath.2010.11.010. Epub 2010 Dec 23.

31.

Proteasome inhibitory activity of thiazole antibiotics.

Pandit B, Bhat UG, Gartel AL.

Cancer Biol Ther. 2011 Jan 1;11(1):43-7. Epub 2011 Jan 1.

32.

ARC synergizes with ABT-737 to induce apoptosis in human cancer cells.

Bhat UG, Pandit B, Gartel AL.

Mol Cancer Ther. 2010 Jun;9(6):1688-96. doi: 10.1158/1535-7163.MCT-09-0919. Epub 2010 Jun 1.

33.

Thiazole antibiotics against breast cancer.

Halasi M, Zhao H, Dahari H, Bhat UG, Gonzalez EB, Lyubimo AV, Tonetti DA, Gartel AL.

Cell Cycle. 2010 Mar 15;9(6):1214-7. Epub 2010 Mar 15. No abstract available.

PMID:
20410687
34.

Nucleoside analog ARC targets Mcl-1 to induce apoptosis in leukemia cells.

Bhat UG, Gartel AL.

Leukemia. 2010 Apr;24(4):851-5. doi: 10.1038/leu.2010.3. Epub 2010 Feb 18. No abstract available.

35.

A new target for proteasome inhibitors: FoxM1.

Gartel AL.

Expert Opin Investig Drugs. 2010 Feb;19(2):235-42. doi: 10.1517/13543780903563364. Review.

36.

New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer.

Pandit B, Gartel AL.

Prostate. 2010 Jun 1;70(8):825-33. doi: 10.1002/pros.21116.

37.

p53 negatively regulates expression of FoxM1.

Pandit B, Halasi M, Gartel AL.

Cell Cycle. 2009 Oct 15;8(20):3425-7. Epub 2009 Oct 25.

PMID:
19806025
38.

FoxM1 is a general target for proteasome inhibitors.

Bhat UG, Halasi M, Gartel AL.

PLoS One. 2009 Aug 12;4(8):e6593. doi: 10.1371/journal.pone.0006593.

39.

Wild-type p53 protects normal cells against apoptosis induced by thiostrepton.

Halasi M, Schraufnagel DP, Gartel AL.

Cell Cycle. 2009 Sep 1;8(17):2850-1. Epub 2009 Sep 2.

PMID:
19652535
40.

p21(WAF1/CIP1) and cancer: a shifting paradigm?

Gartel AL.

Biofactors. 2009 Mar-Apr;35(2):161-4. doi: 10.1002/biof.26. Review.

PMID:
19449443
41.

Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells.

Bhat UG, Halasi M, Gartel AL.

PLoS One. 2009;4(5):e5592. doi: 10.1371/journal.pone.0005592. Epub 2009 May 18.

42.

A novel mode of FoxM1 regulation: positive auto-regulatory loop.

Halasi M, Gartel AL.

Cell Cycle. 2009 Jun 15;8(12):1966-7. Epub 2009 Jun 9.

PMID:
19411834
43.

[Novel anticancer compounds induce apoptosis in human tumor cells].

Gartel AL.

Ai Zheng. 2008 Jul;27(7):675-6. Chinese. No abstract available.

PMID:
18606057
44.

Novel anticancer compounds induce apoptosis in melanoma cells.

Bhat UG, Zipfel PA, Tyler DS, Gartel AL.

Cell Cycle. 2008 Jun 15;7(12):1851-5. Epub 2008 Jun 30.

PMID:
18583930
45.

Transcriptional inhibitors, p53 and apoptoss.

Gartel AL.

Biochim Biophys Acta. 2008 Dec;1786(2):83-6. doi: 10.1016/j.bbcan.2008.04.004. Epub 2008 May 8. Review.

PMID:
18503775
46.

FoxM1 inhibitors as potential anticancer drugs.

Gartel AL.

Expert Opin Ther Targets. 2008 Jun;12(6):663-5. doi: 10.1517/14728222.12.6.663 .

PMID:
18479213
47.

FOXM1: the Achilles' heel of cancer?

Radhakrishnan SK, Gartel AL.

Nat Rev Cancer. 2008 Mar;8(3):c1; author reply c2. doi: 10.1038/nrc2223-c1. No abstract available.

PMID:
18297053
48.

miRNAs: Little known mediators of oncogenesis.

Gartel AL, Kandel ES.

Semin Cancer Biol. 2008 Apr;18(2):103-10. doi: 10.1016/j.semcancer.2008.01.008. Epub 2008 Jan 16. Review.

PMID:
18295504
49.
50.

P21(WAF1/CIP1) may be a tumor suppressor after all.

Gartel AL.

Cancer Biol Ther. 2007 Aug;6(8):1171-2. Epub 2007 Jul 9.

PMID:
17726367

Supplemental Content

Loading ...
Support Center